H-Thr(tBu)-OtBu

H-Thr(tBu)-OtBu is a protected threonine derivative presented as an N-unprotected, C-terminal tert-butyl ester with a side-chain tert-butyl-protected hydroxyl group, giving a chiral amino acid intermediate with the stereochemical integrity of L-threonine retained at the α-carbon. The molecule contains a free primary amino group (H-) for chemoselective coupling, while the carboxyl functionality is masked as a tert-butyl ester (-COOtBu) to suppress premature amide formation or salt formation during peptide assembly. The threonine side-chain hydroxyl is protected as a tert-butyl ether (-O-tBu), reducing hydrogen-bonding and improving compatibility with peptide coupling conditions. The combined tert-butyl ester/ether protection pattern creates a predictable deprotection profile under acid-mediated conditions, enabling downstream conversion to the native amino acid functionality and supporting controlled peptide and derivatization chemistry.

1. Protected Amino Acid Synthesis

H-Thr(tBu)-OtBu serves as a protected amino acid building block for preparing peptide-grade threonine derivatives in synthetic organic chemistry and biochemical research intermediate workflows. The free amino group enables direct incorporation into peptide coupling sequences, while the tert-butyl ester and tert-butyl ether protect the carboxyl and side-chain hydroxyl functionalities from side reactions such as ester aminolysis, transesterification, or uncontrolled O-acylation. The protected threonine architecture supports stepwise protection strategies where N- and O-functionalities can be orthogonally managed relative to other residues bearing different protecting groups. Deprotection of the tert-butyl ester and ether can regenerate the native threonine carboxylate and hydroxyl for subsequent derivatization, including formation of amides, activation for coupling, or conversion to functional side-chain analogs. H-Thr(tBu)-OtBu therefore functions as a chiral intermediate aligned with protected amino acid synthesis and peptide building block preparation.

2. Peptide Coupling Chemistry

H-Thr(tBu)-OtBu is suitable for peptide synthesis workflows that require threonine residues with a protected side-chain hydroxyl to maintain chemoselectivity during chain assembly. The α-amino group participates in standard peptide coupling chemistry, while the tert-butyl ester at the C-terminus can be used to control end-group reactivity during sequential fragment coupling or iterative elongation strategies. The tert-butyl-protected side-chain hydroxyl minimizes competing reactions with activated acyl species, supporting cleaner formation of the desired backbone amide bonds. After peptide assembly, acid-mediated removal of tert-butyl groups can expose the threonine hydroxyl for subsequent phosphorylation-mimic chemistry, glycosylation handle installation, or additional functional group transformations. H-Thr(tBu)-OtBu thus supports peptide coupling chemistry where stereochemically defined threonine incorporation and protected side-chain management are essential.

3. Side-Chain Functionalization

H-Thr(tBu)-OtBu enables side-chain functionalization strategies targeting the threonine hydroxyl as a modifiable handle for downstream chemical biology and materials-oriented conjugation. The tert-butyl ether protection suppresses premature oxidation, esterification, or crosslinking during earlier synthetic steps, allowing the hydroxyl to remain inert until a deliberate deprotection event. Regenerated threonine hydroxyl can be converted into activated intermediates for O-alkylation, O-acylation, or phosphorylation-mimetic motifs, supporting construction of threonine-containing peptidomimetics and substrate analogs. The chiral center and defined stereochemistry of the threonine residue can be retained through these transformations, which is relevant for structure-activity relationship studies where stereochemical presentation of functional groups affects molecular recognition. H-Thr(tBu)-OtBu therefore functions as a controlled precursor for amino acid derivatization and side-chain reactivity programming.

4. Chemical Biology Labeling

H-Thr(tBu)-OtBu can be applied in chemical biology research as a threonine-containing intermediate used to generate hydroxyl-functional probes and labeled peptide scaffolds. The protected threonine side-chain hydroxyl, masked as a tert-butyl ether, allows incorporation into longer peptide constructs without unwanted labeling or side reactions, while the free amino group supports coupling into probe-bearing sequences. Post-synthetic deprotection can reveal the hydroxyl for conjugation-site installation, including attachment of linkers, reporter groups, or affinity handles through controlled O-functionalization. The C-terminal tert-butyl ester form can also serve as a synthetic handle for preparing peptide fragments that undergo further activation or conversion to carboxylate-bearing species for conjugation chemistry. H-Thr(tBu)-OtBu thus supports biomolecule modification workflows that rely on precise placement of threonine-derived functional groups.

5. Pharmaceutical Intermediate Preparation

H-Thr(tBu)-OtBu is relevant to pharmaceutical intermediate preparation where protected amino acid derivatives are required for manufacturing-oriented peptide fragment synthesis and controlled deprotection sequencing. The tert-butyl ester and tert-butyl ether protections provide chemical stability under coupling and intermediate handling conditions, reducing variability associated with free carboxylic acids or free hydroxyl groups during multi-step syntheses. The free amino functionality supports formation of amide linkages in peptide fragment assembly, enabling downstream conversion into drug-relevant peptidomimetics, enzyme inhibitors, or scaffold fragments that contain threonine residues. Acid-labile tert-butyl groups can be removed to regenerate reactive threonine functionalities at defined stages, aligning with process chemistry needs for predictable transformations and manageable impurity profiles. H-Thr(tBu)-OtBu therefore fits industrial fine chemical synthesis and pharmaceutical intermediate preparation routes requiring protected amino acid chemistry compatibility.

1. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

2. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

5. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet